Revenue segments as reported by the company.

Cannabis revenue

Distribution revenue

Beverage alcohol revenue

Wellness revenue

Adult-use

Canada - Medical

International - Medical

Bulk

Hemp

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Impairment of Assets

Litigation settlement

Transaction costs

Change in fair value of contingent consideration

Restructuring costs

Other than temporary change in fair value of convertible notes receivable

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Tilray Brands

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Earnings data Q1 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Tilray Brands reports record revenue and optimistic outlook for 2025

Tilray Brands achieved remarkable financial performance in Q4 2024, driven by strategic acquisitions and a focus on innovation. Despite challenges like price compression, the company remains optimistic about future growth opportunities. Tilray's commitment to quality products and innovation positions it well for continued success in the market.

Tilray Brands reports record Q1 revenue growth and global expansion

Tilray Brands delivered a robust performance in Q1 2025, showcasing strong revenue growth, margin improvement, and strategic expansion across its diversified product portfolio.
While facing challenges in a competitive landscape and evolving regulatory environment, Tilray's financial strength, international growth initiatives, and focus on innovation position it well for future success.
By capitalizing on opportunities in wellness products, expanding into new beverage categories, and leveraging strategic partnerships, Tilray is poised for continued growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The Cannabis Business segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution Business segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage Alcohol Business segment refers to the production, marketing, and sale of beverages. The Wellness Business segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tellurian

TransEnterix

Could there be more gains ahead for these recovering companies?

These 3 "Comeback Kid" Stocks Have Already Doubled in 2021

Aphria

The recent reverse merger acquisition of Tilray announcement by Aphria provides an intriguing pseudo-arbitrage opportunity. Initial returns from the start imply a 20%+ gap opportunity.

Aphria And Tilray: Option Strategy Enhances Returns And Mitigates Losses

Canopy Growth

It's good news all around for the marijuana marketers.

Why Canopy Growth, Tilray, and Aphria Stocks All Popped Today

Tilray's products will treat patients with neuropathic pain, epilepsy and multiple sclerosis who aren't getting relief from existing treatments.

Tilray stock soars 10% after company tapped to provide medical cannabis in French study

Tilray (TLRY) stock is heading higher on Tuesday after announcing a deal with France to supply it with medical marijuana. The post TLRY Stock Alert: 7 Things to Know Today About Tilray's Deal With France appeared first on InvestorPlace.

TLRY Stock Alert: 7 Things to Know Today About Tilray's Deal With France

Shares of Tilray Inc. surged 3.6% in premarket trading Tuesday, after the Canada-based cannabis company said it has been selected by France's National Agency for the Safety of Medicines and Health Products (ANSM) to provide medical cannabis products for experimentation. Tilray said it will supply the medical cannabis, starting in the first quarter of 2021, for the duration of the French experiment, which is expected to last for 18 to 24 months.

Tilray's stock surges after being selected to supply cannabis to France's ANSM for experimentation

NANAIMO, British Columbia & PARIS--(BUSINESS WIRE)--Tilray, Inc. (NASDAQ: TLRY), a global pioneer in cannabis production, research, cultivation, and distribution, announced that it has been selected by the French National Agency for the Safety of Medicines and Health Products (ANSM) to supply Good Manufacturing Processes (GMP) certified medical cannabis products for experimentation in France. Tilray will supply GMP-produced medical cannabis products to serve patients in need for the duration of

Tilray® Selected by French National Agency to Supply GMP-Certified Medical Cannabis Products in France

SNDL Inc.

Let's look at four marijuana penny stocks that can deliver multi-fold returns once federal cannabis legalization occurs in the United States. The post 4 Marijuana Penny Stocks for a Blue-Led Government appeared first on InvestorPlace.

4 Marijuana Penny Stocks for a Blue-Led Government

Aurora Cannabis

Cronos Group

The shares of several cannabis stocks are trading lower as cannabis names pullback following recent momentum.

Why Cannabis Stocks Are Trading Lower Today

3D Systems

GameStop

These hot stocks have already more than doubled -- and in one case more than tripled -- this month.

3 Stocks That Have Already Doubled in 2021

HEXO Corp

The moves felt like an investor retreat from recent price rises.

Why These Marijuana Stocks Fell by as Much as 11.7% Today

BlackBerry

Five9

Progyny

Nio, BlackBerry, Tilray, Five9 and Progyny were our top stock trades for Tuesday. Let's check out the charts after a long holiday weekend.

5 Top Stock Trades for Tuesday: NIO, FIVN, TLRY, PGNY, BB

Meet the Marijuana Stock That's Already Doubled in 2021

The stock price of Tilray Inc (NASDAQ:TLRY) has increased by 78.44% this past week as it went from $11.04 on January 11 morning to $19.70 today. This is why it happened.

TLRY Stock Price Increased 78.44% This Past Week: Why It Happened

Tilray shares gained 137% in 2021 so far but they are only up 13% since January 1, 2020, due to its weak performance in 2020. We think Tilray has more upside due to its strong business fundamentals (with Aphria) and its discounted valuation to Canopy and Cronos.

Tilray: Momentum Could Carry The Stock Much Higher

Molson Coors Brewing

Village Farms International

Earnings, rising share prices, and a stock offering are all playing into the action.

Why Cannabis Stocks Are Trading Mixed Today

Tilray (TLRY) stock is soaring higher on Friday after Cantor Fitzgerald increased its price target for merger partner Aphria (APHA). The post TLRY Stock: Why Tilray Shares Are Smoking Today appeared first on InvestorPlace.

TLRY Stock: Why Tilray Shares Are Smoking Today

Innovative Industrial Properties

Block

Marijuana stocks are set to be the rage on Wall Street in hopes of legalization in and around the United States, which calls for keeping an eye on the likes of Tilray (TLRY) and Square (SQ).

3 Marijuana Stocks to Play the Green Rush in 2021

Cantor Fitzgerald raised its 12-month stock price target for Canadian cannabis company Aphria Inc. to C$26 from C$11.75 on Friday, to factor in its merger with Tilray Inc. even though it was unimpressed by the company's quarterly earnings released on Thursday. "We were disappointed by the Nov qtr reported by APHA.TO on 1/14 (yes, the stock was up 20%, but we think other reasons were at play), but that would be like saying that President-elect Biden, VP-elect Harris, and just-elected Senators Warnock and Ossoff, all had a bad hair day," analyst Pablo Zuanic wrote in a note to clients.

Aphria price target raised by Cantor to reflect merger with Tilray as analyst deems earnings disappointing

Earnings from Aphria are moving Tilray shares today.

Here's Why Tilray Stock Soared 22% Today

Aphria Inc. posted net cannabis revenue of CA$67.9 million for the second quarter of 2021 — 99% higher than in the prior-year quarter.

Aphria Posts Higher Revenue, Plans To Close Tilray Deal In Q2

Why Marijuana Stocks Jumped Today

Is (TLRY) Outperforming Other Medical Stocks This Year?

Is Tilray (TLRY) Stock Outpacing Its Medical Peers This Year?

Beazer Homes USA

JPMorgan Chase & Co

NVIDIA

Tesla

We have highlighted stocks worth a look from the five best trading areas of the current year. This includes NVIDIA (NVDA), JPMorgan Chase (JPM), Beazer Homes (BZH), Tesla (TSLA) and Tilray (TLRY).

Here're the 5 Top Stock Trades for 2021

Curaleaf Holdings, Inc.

When is the right time to buy stock in the cannabis market? The time is now!

The Future of Cannabis Stocks in 2021

News for Tilray Brands Stock (TLRY)